We observed a significantly increased rate of tumor growth in LNCaP xenografts expressing ACSL4 (n = 10 mice per group per clone) (Figure 2M) compared to vector controls (n = 10) (p < 0.0001) consistent with the data derived from in vitro experiments. This evidence concerns the gene ACSL4 and neoplasm.